Related Experiment Video
Updated: Jul 18, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
SEPPIC vaccine adjuvants for poultry.
L Dupuis1, S Ascarateil, J Aucouturier
1SEPPIC, 75 quai d'Orsay, 75321 Paris, Cedex 07, France. laurent.dupuis@airliquide.com
This study improved poultry vaccines using novel oil-in-water emulsions. New formulations with Montanide adjuvants enhanced vaccine safety and efficacy against Newcastle disease and Pasteurella Multocida.
Area of Science:
- Veterinary immunology
- Vaccine formulation science
Background:
- Traditional poultry vaccines face challenges in balancing efficacy and safety.
- Oil-based emulsions are commonly used as vaccine adjuvants.
Purpose of the Study:
- To evaluate novel oil-based emulsion formulations for inactivated poultry vaccines.
- To compare the safety and efficacy of water-in-oil (W/O) and water-in-oil-in-water (W/O/W) emulsions using specific adjuvants.
Main Methods:
- Two inactivated antigens (Newcastle disease virus and Pasteurella Multocida) were formulated with different adjuvants.
- Vaccines were tested in poultry, assessing antibody response, protection against challenge, and local reactions.
- Physicochemical properties of the vaccine formulations were analyzed.
Main Results:
- Water-in-oil (W/O) formulations demonstrated robust efficacy and safety.
- Water-in-oil-in-water (W/O/W) formulations showed enhanced safety with maintained efficacy.
- Montanide ISA 70 (W/O) and Montanide ISA 206 (W/O/W) provided improved safety and efficacy over traditional formulations.
Conclusions:
- Optimized W/O and W/O/W emulsion formulations can significantly improve poultry vaccine performance.
- Montanide ISA 70 and ISA 206 offer distinct advantages for vaccine development, depending on whether efficacy or safety is prioritized.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Vaccine Production
Vaccines
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Smallpox